Jon Gunther, VP Business Development sat down with Dan Stanton, Co-founder and Editor at BioProcess Insider at BIO International Convention 2022 in San Diego as part of the 2022 BPI Theater event.
Jon talked about the J.POD cGMP manufacturing facility in commercial operation in Redmond, WA and the second J.POD facility currently under construction in Toulouse, France*. He continued speaking about Just-Evotec Biologics’ unique intensified, continuous process platform and the benefits it brings in terms of higher productivity compared to traditional fed-batch.
To watch the full interview visit the BioProcess International website
More About The Speaker
 |
Jon GuntherJon brings over 15 years of experience to Just-Evotec Biologics with a track record in technology innovation, process development, strategic sourcing, alliance management, business development, and financial analysis in biopharma and cell & gene therapy. As a strategic manager with a passion for leading, mentoring and developing teams at Just-Evotec, he is dedicated to the development of life-saving therapies for patients. Jon GuntherVP Business Development |
*This project benefits from French government funding as part of the Investments for the future Programme (programme d’investissements d’avenir in French) and is also supported economically by the Occitanie Region and Toulouse Métropole.